FDA Approves Pafolacianine for Identifying Malignant Ovarian Cancer Lesions
An optical imaging agent that targets folate receptor is an adjunct for interoperative identification of malignant lesions in adult patients with ovarian cancer
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Make sure you check these pages frequently, or sign up to our newsletter! To sign up for ESMO newsletters, create a myESMO account here and select the newsletters you’d like to receive.
An optical imaging agent that targets folate receptor is an adjunct for interoperative identification of malignant lesions in adult patients with ovarian cancer
The rate of negative antibody results highest among patients with lymphoid neoplasms
Updated results of the Vax-On study favour the third vaccine dose for actively treated patients with cancer
Findings from an exploratory subgroup analysis of patients included in the MINDACT study
Efficacy was evaluated in Inter-B-NHL Ritux 2010 global randomised study
The results of the final protocol-defined analysis of the PALLAS study conducted in patients with early hormone receptor-positive, HER2-negative breast cancer
Efficacy was evaluated in KEYNOTE-716 study
In a prespecified RxPONDER analysis, postmenopausal women with 1 to 3 positive axillary lymph nodes and a recurrence score of 0 to 25 were able to safely forgo adjuvant chemotherapy for breast cancer
Retrieval of previously unreported data of PD-L1 subgroups from pivotal phase III randomised studies
When classified into gain-of-function and non–gain-of-function, p53 mutations could stratify the prognosis of right-sided versus left-sided metastatic colorectal cancer
Efficacy was evaluated in a single-arm cohort of PLEIADES study
The results from an open-label phase II study in patients with carcinoma of unknown primary
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.